Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Exploring drug response in K-Ras disease mutants - An NMR-based structure activity study

FY 2023-24

Summary
KRAS, a vital member of the Ras subfamily, is the most frequently mutated oncogene in human cancers. Despite originally being considered “undruggable”, understanding K-Ras’ behaviour and its response to drugs has ignited significant interest. The objective of this project is to investigate the intricate relationship between functional states of K-Ras and its disease mutants, ligand binding sites, and the effects of drug binding. The experimental approach involves the expression and purification of K-Ras mutants and the use of a shift reagent which reacts orthogonally towards the protein’s N-terminal cysteine. The shift reagent facilitates the delineation of functional states and improves upon the study of interaction dynamics between the drug and the protein.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506144
Name
Khan Afnan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring drug response in K-Ras disease mutants - An NMR-based structure activity study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Covalent Inhibitors; Disease Mutants; Drug Signatures; Functional States; Interaction Dynamics; K-Ras; Paramagnetic Shift Reagent; Protein Nmr; Structure Activity Relationship (Sar)
Abstract
KRAS, a vital member of the Ras subfamily, is the most frequently mutated oncogene in human cancers. Despite originally being considered “undruggable”, understanding K-Ras’ behaviour and its response to drugs has ignited significant interest. The objective of this project is to investigate the intricate relationship between functional states of K-Ras and its disease mutants, ligand binding sites, and the effects of drug binding. The experimental approach involves the expression and purification of K-Ras mutants and the use of a shift reagent which reacts orthogonally towards the protein’s N-terminal cysteine. The shift reagent facilitates the delineation of functional states and improves upon the study of interaction dynamics between the drug and the protein.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Khan, Afnan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~